Sistema de realidade aumentada em dispositivos móveis para auxiliar no tratamento da doença de Alzheimer

• Ano de defesa: 2011
• Autor(a) principal: Kanno, Keynes Masayoshi
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Uberlândia; BR; Programa de Pós-graduação em Engenharia Elétrica; Engenharias; UFU
• Palavras-chave em Português: Realidade aumentada; Android (Recurso eletrônico); Alzheimer, Doença de; Doença de Alzheimer; Dispositivos móveis; Augmented reality; Alzheimer disease; Mobile device; CNPQ::ENGENHARIAS::ENGENHARIA ELETRICA
• Link de acesso: https://repositorio.ufu.br/handle/123456789/14518; https://doi.org/10.14393/ufu.di.2011.78

This work presents a system for mobile devices using the technology of Augmented Reality (AR) and the Android operating system resources to aid in the treatment of patients with Alzheimer's disease (AD). AR can increase the amount of information available to existing environments, where the information carried by virtual objects help the user to perform real-world tasks. Thus, the system aims to contribute to the pharmacological treatment of AD, allowing the patient to have precision in time to take medication. For this, the system is based on information about drugs, about the time in which drugs must be taken, that trigger alarms at the time that a drug should be taken and information about the time remaining before the drug is taken. This information is trigged from the mobile device when the patient places the phone on the boxes of medicine through the camera of the device. These drugs are previously registered in the system and are associated with AR s markers that are fixed in the drug boxes. Then, when recognizing the marker, the system presents information about the drug. Therefore, it is expected that the system contributes to the daily lives of patients by stimulating the slowing of the disease through drug treatment and the correct memory stimulus through reading and understanding the medicine statement.